Search

everythinglearnresearchcommunity

for

Search:↓

A rabbit with sebaceous adenitis was effectively treated with ciclosporin and medium-chain triglycerides.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Auto-antibody testing is a useful but not definitive tool in diagnosing interstitial lung diseases, and using a specific algorithm could make testing more cost-effective.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

The document concludes that immune system abnormalities cause alopecia areata, but the exact process is still not completely understood.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

The document concludes that mesotherapy can be effective for skin and hair treatments, but more research is needed to confirm its safety and effectiveness.